Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
07/2012
07/12/2012WO2012093919A2 Composition for treating leukemia and method for preparing myrrh extract
07/12/2012WO2012093918A2 Composition including thistle root extract and functional health food
07/12/2012WO2012093917A2 Composition including tussalingo farafara l. extract and functional health food
07/12/2012WO2012093755A1 Composition comprising extracellular vesicles derived from a fermented food and a use therefor
07/12/2012WO2012093754A1 Composition comprising extracellular vesicles derived from inside a mammalian body and a use therefor
07/12/2012WO2012093741A1 Leukaemia-treatment pharmaceutical composition
07/12/2012WO2012093708A1 Novel bicyclic compound or salt thereof
07/12/2012WO2012093707A1 Novel indole or indazole derivative or salt thereof
07/12/2012WO2012093192A1 Coly-mycin derivatives
07/12/2012WO2012093169A1 Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
07/12/2012WO2012093091A2 New saccharide mimics and their use as inhibitors of angiogenesis and metastasis formation
07/12/2012WO2012093068A1 A pharmaceutical composition of a complex of an anti-dig antibody and digoxigenin that is conjugated to a peptide
07/12/2012WO2012092880A1 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS
07/12/2012WO2012092712A1 Lyophilized nanometer particle powder preparation comprising recombinant albumin prepared from human plasma
07/12/2012WO2012092663A1 Monoclonal anti-anti-anti-mhc antibodies and uses thereof
07/12/2012WO2012092645A1 Novel antisense oligonucleotides
07/12/2012WO2012071216A3 Antibodies for tumor gangliosides
07/12/2012WO2012061086A3 Method of treating neuroendocrine tumors
07/12/2012WO2012058241A3 Methods and compositions for ameliorating pancreatic cancer
07/12/2012WO2012058115A3 Anti-cancer serine hydrolase inhibitory carbamates
07/12/2012WO2012040331A3 Multistage nanoparticles
07/12/2012WO2012009508A3 Microrna compositions and methods related thereto
07/12/2012WO2011156751A3 Immunogenic vaccine
07/12/2012WO2011054359A8 Method for early detection of cancer using o - glycosylated mucin peptides or corresponding monoclonal antibodies
07/12/2012US20120178820 Method for treating arthritis
07/12/2012US20120178812 Pharmaceutical Formulations Containing Lipoic Acid Derivatives
07/12/2012US20120178803 Method for treating brain cancer or reducing temozolomide-resistance of brain cancer cells
07/12/2012US20120178793 Nucleotide-cochleate compositions and methods of use
07/12/2012US20120178792 Drg11-responsive (dragon) gene family
07/12/2012US20120178783 Hdac inhibitors
07/12/2012US20120178782 Compositions and methods for treating proliferative diseases
07/12/2012US20120178780 Raf kinase inhibitors
07/12/2012US20120178778 Pyrazolopyridines
07/12/2012US20120178776 Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mglur5 modulators
07/12/2012US20120178770 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
07/12/2012US20120178767 Treatment of liver disorders with p13k inhibitors
07/12/2012US20120178759 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2
07/12/2012US20120178758 Styryl-triazine derivatives and their therapeutical applications
07/12/2012US20120178757 Method For The Prevention Of Cancer Metastasis
07/12/2012US20120178756 Compounds useful as inhibitors of atr kinase
07/12/2012US20120178754 Furazano '3, 4-B! Pyrazines and Their Use as Anti-Tumor Agents
07/12/2012US20120178753 Inhibitors of bruton's tyrosine kinase
07/12/2012US20120178752 Rho kinase inhibitors
07/12/2012US20120178751 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives
07/12/2012US20120178747 Compositions and methods for bone formation and remodeling
07/12/2012US20120178744 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS
07/12/2012US20120178743 Novel adenine compound and use thereof
07/12/2012US20120178741 Sulfonylamino-Derivatives As Novel Inhibitors Of Histone Deacetylase
07/12/2012US20120178740 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
07/12/2012US20120178739 Lactam compounds useful as protein kinase inhibitors
07/12/2012US20120178737 Tricyclic Heterocyclic Compounds as Phosphoinositide 3-Kinase Inhibitors
07/12/2012US20120178725 Method of modulating ship activity
07/12/2012US20120178723 Heteroaryls and uses thereof
07/12/2012US20120178716 Unsaturated Heterocyclic Derivatives
07/12/2012US20120178715 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
07/12/2012US20120178714 Phosphorus-containing Compounds & Uses Thereof
07/12/2012US20120178713 Phenyl sulphonamides as modulators of ion channels
07/12/2012US20120178711 Cyclodextrin-based polymers for therapeutics delivery
07/12/2012US20120178708 Phenethylsulfone isoindoline derivatives and their use
07/12/2012US20120178707 Methods for treating prostrate conditions
07/12/2012US20120178705 Methods for preparation of glycosphingolipids and uses thereof
07/12/2012US20120178704 Prevention and treatment of colon cancer
07/12/2012US20120178700 Peptidomimetic macrocycles
07/12/2012US20120178699 Klotho protein and related compounds for the treatment and diagnosis of cancer
07/12/2012US20120178698 Agents and Uses Thereof
07/12/2012US20120178697 Compositions and methods for the inhibition of dishevelled proteins
07/12/2012US20120178690 Novel netrin derivatives and uses thereof
07/12/2012US20120178682 GB1 Peptidic Compounds and Methods for Making and Using the Same
07/12/2012US20120178679 Fused aromatic ptp-ib inhibitors
07/12/2012US20120178678 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors
07/12/2012US20120178669 Protease inhibitors, compositions and methods of use
07/12/2012US20120178668 Proteinaceous compounds and uses therefor
07/12/2012US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
07/12/2012US20120178157 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
07/12/2012US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
07/12/2012US20120177754 Inhibitor of inflammatory conditions
07/12/2012US20120177752 Nutritional compositions including beta-hydroxy-beta-methylbutyrate
07/12/2012US20120177749 Family of pfkfb3 inhibitors with anti-neoplastic activities
07/12/2012US20120177748 Compounds useful as inhibitors of atr kinase
07/12/2012US20120177744 Method of using beta-hydroxy-beta-methylbutyrate for the treatment of cancer
07/12/2012US20120177743 Combinations and modes of administration of therapeutic agents and combination therapy
07/12/2012US20120177741 Positively-charged poly (d,l-lactide-co-glycolide) nanoparticles and fabrication methods of the same
07/12/2012US20120177740 Drug delivery formulation for controlling of initial burst and manufacturing method thereof
07/12/2012US20120177737 High drug load tablet
07/12/2012US20120177728 Oxaliplatin nanoparticles and method for preparing same
07/12/2012US20120177726 Medical use of spla2 hydrolysable liposomes
07/12/2012US20120177720 Multi-layer wound dressings
07/12/2012US20120177716 Methods for Making Controlled Delivery Devices Having Zero Order Kinetics
07/12/2012US20120177705 Composition 064
07/12/2012US20120177704 Crystalline anti-human il-12 antibodies
07/12/2012US20120177701 Compositions comprising immunostimulatory nucleic acids and related methods
07/12/2012US20120177699 Preparation Method of Drug Loaded Emulsion
07/12/2012US20120177694 Methods and Apparatus for Manufacturing Plasma Based Plastics and Bioplastics Produced Therefrom
07/12/2012US20120177690 Use of rapamycin derivatives in vasculopathies and xenotransplantation
07/12/2012US20120177686 Vaccine for the prevention of acute lymphoblastic leukemia
07/12/2012US20120177679 Matrix metalloproteinase 11 vaccine
07/12/2012US20120177678 Compositions and methods for treatment of cervical dysplasia
07/12/2012US20120177674 Compositions comprising fungal immunomodulatory protein and use thereof
07/12/2012US20120177672 Therapeutic peptides, polypeptides and nucleic acid sequences
07/12/2012US20120177670 Somatic Stem Cells
1 ... 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 ... 2211